Clinical Trial Update: Heartflow (AFFECTS) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Heartflow (AFFECTS) is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Abnormalities

Drugs mentioned

• Heartflow

Snippet

Sponsor: Baylor Research Institute | Conditions: Cardiovascular Abnormalities | Phase 3 | Status: UNKNOWN